Cited by 800COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research

Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019

Open access
Lechien, Jerome R., Chiesa‐Estomba, Carlos M., Place, Sammy, Van Laethem, Yves, Cabaraux, Pierre, Mat, Quentin, Huet, Kathy, Plzak, Jan +11 more·2020·Journal of Internal Medicine

Abstract

Background: The clinical presentation of European patients with mild‐to‐moderate COVID‐19 infection is still unknown. Objective: To study the clinical presentation of COVID‐19 in Europe. Methods: Patients with positive diagnosis of COVID‐19 were recruited from 18 European hospitals. Epidemiological and clinical data were obtained through a standardized questionnaire. Bayesian analysis was used for analysing the relationship between outcomes. Results: A total of 1,420 patients completed the study (962 females, 30.7% of healthcare workers). The mean age of patients was 39.17 ± 12.09 years. The most common symptoms were headache (70.3%), loss of smell (70.2%), nasal obstruction (67.8%), cough (63.2%), asthenia (63.3%), myalgia (62.5%), rhinorrhea (60.1%), gustatory dysfunction (54.2%) and sore throat (52.9%). Fever was reported by 45.4%. The mean duration of COVID‐19 symptoms of mild‐to‐moderate cured patients was 11.5 ± 5.7 days. The prevalence of symptoms significantly varied according to age and sex. Young patients more frequently had ear, nose and throat complaints, whereas elderly individuals often presented fever, fatigue and loss of appetite. Loss of smell, headache, nasal obstruction and fatigue were more prevalent in female patients. The loss of smell was a key symptom of mild‐to‐moderate COVID‐19 patients and was not associated with nasal obstruction and rhinorrhea. Loss of smell persisted at least 7 days after the disease in 37.5% of cured patients. Conclusion: The clinical presentation of mild‐to‐moderate COVID‐19 substantially varies according to the age and the sex characteristics of patients. Olfactory dysfunction seems to be an important underestimated symptom of mild‐to‐moderate COVID‐19 that needs to be recognized as such by the WHO.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/joim.13089

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

Research works printed but not linked: 2

  1. [8]8. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.
  2. [14]14. Mao L, Wang M, Chen S, et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. MedRXiv, in press. 2020.

Cited by

Sorted by citations

Authors
Lechien, J. R., Chiesa‐Estomba, C. M., Place, S., Van Laethem, Y., Cabaraux, P., Mat, Q., Huet, K., Plzak, J., Horoi, M., Hans, S., Rosaria Barillari, M., Cammaroto, G., Fakhry, N., Martiny, D., Ayad, T., Jouffe, L., Hopkins, C., Saussez, S., & COVID‐19 Task Force of YO‐IFOS
Affiliations
  • University of Mons (BE)
  • From COVID‐19 Task Force of the Young‐Otolaryngologists of the International Federations of Oto‐rhino‐laryngological Societies (YO‐IFOS) Paris France
  • Epicura (BE)
  • Department of Internal Medicine, Infectiology CHU Saint‐Pierre Brussels Belgium
  • HUmani - CHU Charleroi-Chimay (BE)
  • Department of Otolaryngology – Head & Neck Surgery 1st Faculty of Medicine University Hospital Motol Prague Czech Republic
  • Université de Versailles Saint-Quentin-en-Yvelines (FR)
  • Ospedale G.B. Morgagni - L.Pierantoni (IT)
  • Aix-Marseille Université (FR)
  • Centre Hospitalier de l’Université de Montréal (CA)
  • Guy's and St Thomas' NHS Foundation Trust (GB)
Corresponding author
Lechien, Jerome R.
Venue
Journal of Internal Medicine
Publisher
Wiley
Published
2020-06-17
Volume
288
Issue
3
Pages
335-344
ISSN
  • 0954-6820 (ISSN-L)
  • 1365-2796
OpenAlex
W3022531685
Cited by
800
References
20
Citations by year
2026: 14 · 2025: 25 · 2024: 47 · 2023: 78 · 2022: 154 · 2021: 296 · 2020: 185
FWCI
23.26
Type
journal article
Language
en
Open access
Locations
  • Journal of Internal Medicine (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • ORBi UMONS (submittedVersion, other-oa)
  • HAL (submittedVersion)
  • HAL AMU (submittedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, other-oa)
  • Florence Research (University of Florence) (submittedVersion)
  • Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
  • Oskar-Bordeaux (Universite de Bordeaux) (submittedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
COVID-19 pandemic, SARS-CoV-2, mild to moderate COVID-19, clinical features, epidemiological characteristics, olfactory dysfunction, anosmia, headache, nasal obstruction, rhinorrhea, fever, symptom duration, age and sex differences, healthcare workers
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, Adult, Age Factors, Olfaction Disorders, Bayes Theorem, Europe, Female, Headache, Humans, Male, Middle Aged, Pneumonia, Viral, Sex Factors, Taste Disorders, Prevalence, Coronavirus Infections, Pandemics, Symptom Assessment, Myalgia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review